Antonio Gentilella

1.6k total citations
24 papers, 1.0k citations indexed

About

Antonio Gentilella is a scholar working on Molecular Biology, Oncology and Electrical and Electronic Engineering. According to data from OpenAlex, Antonio Gentilella has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Electrical and Electronic Engineering. Recurrent topics in Antonio Gentilella's work include RNA modifications and cancer (7 papers), RNA and protein synthesis mechanisms (6 papers) and Heat shock proteins research (6 papers). Antonio Gentilella is often cited by papers focused on RNA modifications and cancer (7 papers), RNA and protein synthesis mechanisms (6 papers) and Heat shock proteins research (6 papers). Antonio Gentilella collaborates with scholars based in Spain, United States and Italy. Antonio Gentilella's co-authors include Kamel Khalili, Sara C. Kozma, George Thomas, Maria Caterina Turco, Albert Tauler, Massimo Ammirante, Maria Pascale, Michela Festa, Maria Antonietta Belisario and Alessandra Rosati and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Antonio Gentilella

24 papers receiving 994 citations

Peers

Countries citing papers authored by Antonio Gentilella

Since Specialization

Citations

This map shows the geographic impact of Antonio Gentilella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Gentilella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Gentilella more than expected).

Fields of papers citing papers by Antonio Gentilella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Gentilella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Gentilella. The network helps show where Antonio Gentilella may publish in the future.

Co-authorship network of co-authors of Antonio Gentilella

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Gentilella. A scholar is included among the top collaborators of Antonio Gentilella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Gentilella. Antonio Gentilella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death 2021 ·Blood ·(unknown), Suresh Peddigari, Carol A. Mercer, (unknown), (unknown), (unknown), Virginia Amador, Sarah T. Diepstraten, Gemma L. Kelly, Ramón Salazar, Sara C. Kozma, Eric Kusnadi, Jian Kang, Antonio Gentilella, Richard B. Pearson, George Thomas, Joffrey Pelletier	17
2	Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis 2021 ·Nature Communications ·Jeannine Diesch, (unknown), (unknown), (unknown), Matthias Muhar, Mark van der Garde, Michael P. Maher, (unknown), Joan Josep Bech‐Serra, Michaela Fellner, Philipp Rathert, Nigel Brooks, Lurdes Zamora, Antonio Gentilella, Carolina de la Torre, Johannes Zuber, Katharina S. Götze, Marcus Buschbeck	16
3	The 40 S -LARP1 complex reprograms the cellular translatome upon mTOR inhibition to preserve the protein synthetic capacity 2021 ·Science Advances ·Pedro Juan Barrios Fuentes, Joffrey Pelletier, (unknown), Virginia Díez‐Obrero, (unknown), Teresa Rubio, (unknown), (unknown), Vı́ctor Moreno, Ramón Salazar, Albert Tauler, Antonio Gentilella	21
4	Nucleotide depletion reveals the impaired ribosome biogenesis checkpoint as a barrier against DNA damage 2020 ·The EMBO Journal ·Joffrey Pelletier, (unknown), Eugènia Almacellas, Caroline Mauvezin, Sara Samino, (unknown), (unknown), (unknown), (unknown), Ramón Salazar, Constanza Cortés, Ricard Marcos, Albert Tauler, Óscar Yanes, Neus Agell, Sara C. Kozma, Antonio Gentilella, George Thomas	28
5	Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content 2019 ·Cancer Research ·(unknown), (unknown), (unknown), Albert Tauler, Sara C. Kozma, George Thomas, Antonio Gentilella	28
6	The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition 2019 ·Nature Communications ·Cristina Oliveira-Mateos, (unknown), Marta Soler, (unknown), David Piñeyro, Raquel Boqué-Sastre, María Eréndira Calleja-Cervantes, Manuel Castro de Moura, Anna Martínez‐Cardús, Teresa Rubio, Joffrey Pelletier, María Martínez‐Iniesta, David Herrero‐Martín, Òscar M. Tirado, Antonio Gentilella, Alberto Villanueva, Manel Esteller, Lourdes Farré, Sònia Guil	45
7	Phosphofructokinases Axis Controls Glucose-Dependent mTORC1 Activation Driven by E2F1 2019 ·iScience ·Eugènia Almacellas, Joffrey Pelletier, Ànna Manzano, Antonio Gentilella, Santiago Ambrosio, Caroline Mauvezin, Albert Tauler	28
8	Autogenous Control of 5′TOP mRNA Stability by 40S Ribosomes 2017 ·Molecular Cell ·Antonio Gentilella, (unknown), Pedro Juan Barrios Fuentes, Guilherme Z. Rocha, (unknown), Joffrey Pelletier, (unknown), Gemma Turón, Julio Castaño, Albert Tauler, Clara Bueno, Pablo Menéndez, Sara C. Kozma, George Thomas	83
9	A liaison between mTOR signaling, ribosome biogenesis and cancer 2015 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Antonio Gentilella, Sara C. Kozma, George Thomas	100
10	V-ATPase: a master effector of E2F1-mediated lysosomal trafficking, mTORC1 activation and autophagy 2015 ·Oncotarget ·(unknown), Eugènia Almacellas, (unknown), Antonio Gentilella, Santiago Ambrosio, Sara C. Kozma, George Thomas, Albert Tauler	38
11	Exploiting Tumor Vulnerabilities: Epigenetics, Cancer Metabolism and the mTOR Pathway in the Era of Personalized Medicine 2013 ·Cancer Research ·Cristina Muñoz‐Pinedo, Eva González‐Suárez, Anna Portela, Antonio Gentilella, Manel Esteller	4
12	BAG3 Expression in Glioblastoma Cells Promotes Accumulation of Ubiquitinated Clients in an Hsp70-dependent Manner 2011 ·Journal of Biological Chemistry ·Antonio Gentilella, Kamel Khalili	37
13	Induction of Id-1 by FGF-2 involves activity of EGR-1 and sensitizes neuroblastoma cells to cell death 2010 ·Journal of Cellular Physiology ·(unknown), Antonio Gentilella, Slava Rom, Marco Pacifici, (unknown), Francesca Peruzzi	20
14	Autoregulation of co‐chaperone BAG3 gene transcription 2009 ·Journal of Cellular Biochemistry ·Antonio Gentilella, Kamel Khalili	24
15	Detection of JC virus DNA fragments but not proteins in normal brain tissue 2008 ·Annals of Neurology ·(unknown), Luis Del Valle, Antonio Gentilella, Sidney Croul, Kamel Khalili	97
16	Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells 2008 ·Oncogene ·Antonio Gentilella, (unknown), Satish L. Deshmane, Maria Caterina Turco, Kamel Khalili	36
17	The activity of hsp90α promoter is regulated by NF-κB transcription factors 2007 ·Oncogene ·Massimo Ammirante, Alessandra Rosati, Antonio Gentilella, Michelina Festa, Antonello Petrella, Liberato Marzullo, Maria Pascale, Maria Antonietta Belisario, Alessia Leone, Maria Caterina Turco	59
18	Apoptosis inhibition in cancer cells: A novel molecular pathway that involves BAG3 protein 2007 ·The International Journal of Biochemistry & Cell Biology ·Alessandra Rosati, Massimo Ammirante, Antonio Gentilella, Anna Basile, Michela Festa, Maria Pascale, Liberato Marzullo, Maria Antonietta Belisario, Alessandra Tosco, Silvia Franceschelli, Ornella Moltedo, (unknown), Rosa Lerose, Maria Caterina Turco	111
19	Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction 2006 ·European Journal of Cancer ·Antonello Petrella, (unknown), Michela Festa, Antonio Gentilella, Alessandra Tosco, Suzanne D. Conzen, Luca Parente	43
20	1-Methoxy-Canthin-6-One Induces c-Jun NH2-Terminal Kinase–Dependent Apoptosis and Synergizes with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Activity in Human Neoplastic Cells of Hematopoietic or Endodermal Origin 2006 ·Cancer Research ·Massimo Ammirante, (unknown), Laura De Martino, Alessandra Rosati, Michela Festa, Antonio Gentilella, Maria Pascale, Maria Antonietta Belisario, Arturo Leone, Maria Caterina Turco, Vincenzo De Feo	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact